Clinical Trial Update: Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine [Phase 1]

View source ↗

Summary

Phase I study of a bivalent Enterovirus 71 and Coxsackievirus A16 vaccine for Hand, Foot and Mouth Disease, not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine

Snippet

Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences | Conditions: Hand, Foot and Mouth Disease (HFMD), HFMD | Phase 1 | Status: NOT_YET_RECRUITING